Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways

被引:16
作者
Agbottah E. [1 ]
Yeh W.-I. [1 ]
Berro R. [1 ]
Klase Z. [1 ]
Pedati C. [1 ]
Kehn-Hall K. [1 ]
Wu W. [1 ]
Kashanchi F. [1 ,2 ,3 ]
机构
[1] Department of Microbiology and tropical Medicine, Department of Biochemistry and Molecular Biology, The George Washington University School of Medicine, Washington
[2] Department of Microbiology, Institute for Proteomics Technology and Applications, The George Washington University, Washington
[3] The Institute for Genomic Research, TIGR, Rockville
基金
美国国家卫生研究院;
关键词
Uninfected Cell; Arsenic Trioxide; Caffeic Acid Phenylethyl Ester;
D O I
10.1186/1742-6405-5-12
中图分类号
学科分类号
摘要
Human T-cell leukemia virus type-1 (HTLV-1) induces adult T-cell leukemia/lymphoma (ATL/L), a fatal lymphoproliferative disorder, and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic progressive disease of the central nervous system after a long period of latent infection. Although the mechanism of transformation and leukemogenesis is not fully elucidated, there is evidence to suggest that the viral oncoprotein Tax plays a crucial role in these processes through the regulation of several pathways including NF-κB and the cell cycle pathways. The observation that NF-κB, which is strongly induced by Tax, is indispensable for the maintenance of the malignant phenotype of HTLV-1 by regulating the expression of various genes involved in cell cycle regulation and inhibition of apoptosis provides a possible molecular target for these infected cells. To develop potential new therapeutic strategies for HTLV-1 infected cells, in this present study, we initially screened a battery of NF-κB and CDK inhibitors (total of 35 compounds) to examine their effects on the growth and survival of infected T-cell lines. Two drugs namely BMS-345541 and Purvalanol A exhibited higher levels of growth inhibition and apoptosis in infected cell as compared to uninfected cells. BMS-345541 inhibited IKKβ kinase activity from HTLV-1 infected cells with an IC50 (the 50% of inhibitory concentration) value of 50 nM compared to 500 nM from control cells as measured by in vitro kinase assays. The effects of Purvalanol A were associated with suppression of CDK2/cyclin E complex activity as previously shown by us. Combination of both BMS-345541 and Purvalanol A showed a reduced level of HTLV-1 p19 Gag production in cell culture. The apparent apoptosis in these infected cells were associated with increased caspase-3 activity and PARP cleavage. The potent and selective apoptotic effects of these drugs suggest that both BMS-345541 and Purvalanol A, which target both NF-κB and CDK complex and the G1/S border, might be promising new agents in the treatment of these infected patients. © 2008 Agbottah et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 87 条
[1]  
Verdonck K., Gonzalez E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E., Human T-lymphotropic virus 1: Recent knowledge about an ancient infection, Lancet Infect Dis, 7, pp. 266-281, (2007)
[2]  
Matsuoka M., Jeang K.T., Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation, Nat Rev Cancer, 7, pp. 270-280, (2007)
[3]  
Peloponese Jr. J.M., Kinjo T., Jeang K.T., Human T-cell leukemia virus type 1 Tax and cellular transformation, Int J Hematol, 86, pp. 101-106, (2007)
[4]  
Suzuki T., Hirai H., Yoshida M., Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription, Oncogene, 9, pp. 3099-3105, (1994)
[5]  
Yin M.J., Christerson L.B., Yamamoto Y., Kwak Y.T., Xu S., Mercurio F., Barbosa M., Cobb M.H., Gaynor R.B., HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation, Cell, 93, pp. 875-884, (1998)
[6]  
Xiao G., Cvijic M.E., Fong A., Harhaj E.W., Uhlik M.T., Waterfield M., Sun S.C., Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: Evidence for the involvement of IKKalpha, Embo J, 20, pp. 6805-6815, (2001)
[7]  
Caron C., Rousset R., Beraud C., Moncollin V., Egly J.M., Jalinot P., Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP, Embo J, 12, pp. 4269-4278, (1993)
[8]  
Clemens K.E., Piras G., Radonovich M.F., Choi K.S., Duvall J.F., DeJong J., Roeder R., Brady J.N., Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA, Mol Cell Biol, 16, pp. 4656-4664, (1996)
[9]  
Colgin M.A., Nyborg J.K., The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein, J Virol, 72, pp. 9396-9399, (1998)
[10]  
Gachon F., Thebault S., Peleraux A., Devaux C., Mesnard J.M., Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4), Mol Cell Biol, 20, pp. 3470-3481, (2000)